Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01861248 |
2 | immunoglobulin mediated immune response (GO:0016064) | 4.55672789 |
3 | response to peptidoglycan (GO:0032494) | 4.50933845 |
4 | negative regulation of interleukin-12 production (GO:0032695) | 4.43439151 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.35712709 |
6 | modulation by symbiont of host defense response (GO:0052031) | 4.35712709 |
7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.35712709 |
8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.35712709 |
9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.35712709 |
10 | modulation by symbiont of host immune response (GO:0052553) | 4.35712709 |
11 | type I interferon signaling pathway (GO:0060337) | 4.24326931 |
12 | cellular response to type I interferon (GO:0071357) | 4.24326931 |
13 | response to type I interferon (GO:0034340) | 4.19175954 |
14 | macrophage activation involved in immune response (GO:0002281) | 4.10279188 |
15 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.01686912 |
16 | negative regulation of microtubule polymerization (GO:0031115) | 3.96822824 |
17 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.96048008 |
18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.85416895 |
19 | negative regulation of cell killing (GO:0031342) | 3.83838160 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83838160 |
21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82967560 |
22 | detection of other organism (GO:0098543) | 3.80133037 |
23 | neutrophil activation involved in immune response (GO:0002283) | 3.79825782 |
24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76900243 |
25 | regulation of interferon-alpha production (GO:0032647) | 3.75231162 |
26 | T-helper 1 type immune response (GO:0042088) | 3.74144346 |
27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66932235 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65281273 |
29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.64575923 |
30 | detection of bacterium (GO:0016045) | 3.62286799 |
31 | B cell mediated immunity (GO:0019724) | 3.61976301 |
32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61818427 |
33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59752358 |
34 | histone arginine methylation (GO:0034969) | 3.59398052 |
35 | cullin deneddylation (GO:0010388) | 3.58264461 |
36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57704346 |
37 | NIK/NF-kappaB signaling (GO:0038061) | 3.57044635 |
38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55754703 |
39 | positive regulation of interferon-alpha production (GO:0032727) | 3.52358104 |
40 | protein deneddylation (GO:0000338) | 3.51064894 |
41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.49920516 |
42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.47259453 |
43 | germinal center formation (GO:0002467) | 3.45342178 |
44 | T cell migration (GO:0072678) | 3.42312448 |
45 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.42286384 |
46 | regulation of antigen processing and presentation (GO:0002577) | 3.41471477 |
47 | defense response to protozoan (GO:0042832) | 3.41031410 |
48 | myeloid dendritic cell differentiation (GO:0043011) | 3.40254714 |
49 | DNA unwinding involved in DNA replication (GO:0006268) | 3.37078116 |
50 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.36427151 |
51 | positive regulation of type 2 immune response (GO:0002830) | 3.35817329 |
52 | detection of molecule of bacterial origin (GO:0032490) | 3.35210686 |
53 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.32483512 |
54 | response to protozoan (GO:0001562) | 3.31801055 |
55 | myeloid dendritic cell activation (GO:0001773) | 3.29344004 |
56 | response to muramyl dipeptide (GO:0032495) | 3.29172230 |
57 | formation of translation preinitiation complex (GO:0001731) | 3.29144691 |
58 | detection of external biotic stimulus (GO:0098581) | 3.28673188 |
59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.27818124 |
60 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.24936544 |
61 | negative regulation of ligase activity (GO:0051352) | 3.24936544 |
62 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.20069175 |
63 | ATP synthesis coupled proton transport (GO:0015986) | 3.20069175 |
64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18432413 |
65 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.17954151 |
66 | establishment of integrated proviral latency (GO:0075713) | 3.17757660 |
67 | response to host immune response (GO:0052572) | 3.15898378 |
68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15898378 |
69 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.15712070 |
70 | cellular response to interferon-gamma (GO:0071346) | 3.12534927 |
71 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.12224592 |
72 | B cell receptor signaling pathway (GO:0050853) | 3.11429117 |
73 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.10267452 |
74 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.10238588 |
75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10156145 |
76 | proteasome assembly (GO:0043248) | 3.07628015 |
77 | positive regulation of B cell differentiation (GO:0045579) | 3.05087086 |
78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03618564 |
79 | regulation of interleukin-12 production (GO:0032655) | 2.99100300 |
80 | viral transcription (GO:0019083) | 2.98581998 |
81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97875549 |
82 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96397187 |
83 | de novo posttranslational protein folding (GO:0051084) | 2.95535654 |
84 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.95238131 |
85 | de novo protein folding (GO:0006458) | 2.94785524 |
86 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.93644670 |
87 | myeloid cell activation involved in immune response (GO:0002275) | 2.92396918 |
88 | detection of biotic stimulus (GO:0009595) | 2.90835016 |
89 | DNA strand elongation (GO:0022616) | 2.89044032 |
90 | response to host (GO:0075136) | 2.88279371 |
91 | response to host defenses (GO:0052200) | 2.88279371 |
92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88279371 |
93 | response to interferon-gamma (GO:0034341) | 2.87570061 |
94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86426784 |
95 | translational termination (GO:0006415) | 2.85547077 |
96 | cellular extravasation (GO:0045123) | 2.85400558 |
97 | regulation of T cell tolerance induction (GO:0002664) | 2.84445165 |
98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84425145 |
99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84329924 |
100 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.83934003 |
101 | chaperone-mediated protein transport (GO:0072321) | 2.82906075 |
102 | peptidyl-arginine methylation (GO:0018216) | 2.82656871 |
103 | peptidyl-arginine N-methylation (GO:0035246) | 2.82656871 |
104 | granulocyte activation (GO:0036230) | 2.82226582 |
105 | regulation of type 2 immune response (GO:0002828) | 2.82181251 |
106 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.80873966 |
107 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.80408550 |
108 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80345753 |
109 | DNA replication initiation (GO:0006270) | 2.80297915 |
110 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.80212704 |
111 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.78638506 |
112 | establishment of viral latency (GO:0019043) | 2.78632389 |
113 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78519297 |
114 | regulation of protein heterodimerization activity (GO:0043497) | 2.78213063 |
115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.76473458 |
116 | macrophage activation (GO:0042116) | 2.76329933 |
117 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.76089297 |
118 | dendritic cell differentiation (GO:0097028) | 2.75490042 |
119 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72915621 |
120 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72915621 |
121 | spliceosomal snRNP assembly (GO:0000387) | 2.72882955 |
122 | positive regulation of interferon-beta production (GO:0032728) | 2.72429729 |
123 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.72404519 |
124 | regulation of podosome assembly (GO:0071801) | 2.71413768 |
125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71396833 |
126 | microglial cell activation (GO:0001774) | 2.71172447 |
127 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.71013984 |
128 | positive regulation of interleukin-10 production (GO:0032733) | 2.70392001 |
129 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70345705 |
130 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68826862 |
131 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.67911121 |
132 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67322739 |
133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67322739 |
134 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67322739 |
135 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66975953 |
136 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66975953 |
137 | translational elongation (GO:0006414) | 2.66880707 |
138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.66492817 |
139 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66089828 |
140 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66089828 |
141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.65154843 |
142 | ribosomal small subunit biogenesis (GO:0042274) | 2.64997400 |
143 | positive regulation of ligase activity (GO:0051351) | 2.64536964 |
144 | regulation of T-helper cell differentiation (GO:0045622) | 2.63674335 |
145 | sequestering of actin monomers (GO:0042989) | 2.63642343 |
146 | regulation of vitamin metabolic process (GO:0030656) | 2.63607308 |
147 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63578230 |
148 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.63227484 |
149 | translational initiation (GO:0006413) | 2.62616219 |
150 | protein neddylation (GO:0045116) | 2.59353990 |
151 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.57725913 |
152 | mitotic sister chromatid segregation (GO:0000070) | 2.55785302 |
153 | viral mRNA export from host cell nucleus (GO:0046784) | 2.55641410 |
154 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.52954403 |
155 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.52954403 |
156 | cellular protein complex disassembly (GO:0043624) | 2.51850713 |
157 | regulation of ligase activity (GO:0051340) | 2.48783526 |
158 | cotranslational protein targeting to membrane (GO:0006613) | 2.48257044 |
159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.45042824 |
160 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.44793132 |
161 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.42411832 |
162 | viral life cycle (GO:0019058) | 2.41826531 |
163 | protein targeting to ER (GO:0045047) | 2.41232742 |
164 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.41157940 |
165 | establishment of protein localization to mitochondrion (GO:0072655) | 2.39066106 |
166 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.38350742 |
167 | protein complex disassembly (GO:0043241) | 2.38043346 |
168 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.36695072 |
169 | synaptic vesicle exocytosis (GO:0016079) | 2.35101574 |
170 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.34882541 |
171 | 7-methylguanosine mRNA capping (GO:0006370) | 2.34678297 |
172 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.32834471 |
173 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.32737708 |
174 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.32737708 |
175 | maturation of SSU-rRNA (GO:0030490) | 2.32128682 |
176 | barbed-end actin filament capping (GO:0051016) | 2.31834946 |
177 | translation (GO:0006412) | 2.30168906 |
178 | base-excision repair, AP site formation (GO:0006285) | 2.29156667 |
179 | 7-methylguanosine RNA capping (GO:0009452) | 2.29145100 |
180 | RNA capping (GO:0036260) | 2.29145100 |
181 | mitotic spindle assembly checkpoint (GO:0007094) | 2.28417926 |
182 | macromolecular complex disassembly (GO:0032984) | 2.27912907 |
183 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.27904703 |
184 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.27823128 |
185 | spliceosomal complex assembly (GO:0000245) | 2.27730813 |
186 | negative regulation of chromosome segregation (GO:0051985) | 2.27144303 |
187 | positive regulation of cell cycle arrest (GO:0071158) | 2.27008135 |
188 | protein localization to endoplasmic reticulum (GO:0070972) | 2.26765337 |
189 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.26745431 |
190 | ribosomal small subunit assembly (GO:0000028) | 2.25301186 |
191 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.25001456 |
192 | DNA replication checkpoint (GO:0000076) | 2.23627858 |
193 | protein insertion into membrane (GO:0051205) | 2.22957624 |
194 | negative regulation of protein ubiquitination (GO:0031397) | 2.22168337 |
195 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.21346298 |
196 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.21092659 |
197 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.21092659 |
198 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.21092659 |
199 | negative regulation of sister chromatid segregation (GO:0033046) | 2.21092659 |
200 | protein targeting to mitochondrion (GO:0006626) | 2.20844910 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.30232581 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.04504547 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.55909275 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.37081949 |
5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70863902 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70766732 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.51980296 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50166079 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.48502973 |
10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33649755 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.33499778 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32032782 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.31688009 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.24112472 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14839621 |
16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.09850092 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05134738 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.99802099 |
19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.97266932 |
20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.93442082 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87775568 |
22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.87260037 |
23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.76134875 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.74591935 |
25 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.74145368 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.68538412 |
27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.62804460 |
28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.60798824 |
29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59572108 |
30 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57824859 |
31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54313920 |
32 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.47018763 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44904266 |
34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.39846127 |
35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.38420967 |
36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.37604189 |
37 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.31263301 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15394710 |
39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.15292789 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13754372 |
41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12026473 |
42 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.09159964 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07698487 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 2.05382755 |
45 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05296577 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02797543 |
47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02489386 |
48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96000693 |
49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.95719572 |
50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95002924 |
51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.94810016 |
52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.94543525 |
53 | * MYB_26560356_Chip-Seq_TH2_Human | 1.86996713 |
54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86909546 |
55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86864916 |
56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85568985 |
57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83538264 |
58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.82183027 |
59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81296373 |
60 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79646135 |
61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79497503 |
62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79069319 |
63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78637604 |
64 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.78337370 |
65 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.77002845 |
66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.76999476 |
67 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76344394 |
68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75813250 |
69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.74593563 |
70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.71877346 |
71 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.70770587 |
72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69396611 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67660612 |
74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.67577414 |
75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66836823 |
76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61724089 |
77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.61006619 |
78 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.60185282 |
79 | MYB_26560356_Chip-Seq_TH1_Human | 1.58761130 |
80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58210087 |
81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57373615 |
82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57244247 |
83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52950965 |
84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51774800 |
85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51392519 |
86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51319946 |
87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51177941 |
88 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.49602032 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.49554382 |
90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45724105 |
91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.45470197 |
92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45211539 |
93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44603489 |
94 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.44479950 |
95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43582188 |
96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41756241 |
97 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.38845509 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38318647 |
99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37234971 |
100 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36993794 |
101 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36989087 |
102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36769671 |
103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35443671 |
104 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35314812 |
105 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34969510 |
106 | MAF_26560356_Chip-Seq_TH2_Human | 1.34850679 |
107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33091989 |
108 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32795821 |
109 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32038152 |
110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31971913 |
111 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30634432 |
112 | MYC_22102868_ChIP-Seq_BL_Human | 1.30172287 |
113 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.27665090 |
114 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.27001983 |
115 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.27001983 |
116 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.27001983 |
117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26502761 |
118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25766025 |
119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24291399 |
120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23690941 |
121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23672616 |
122 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23218926 |
123 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22947280 |
124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21784635 |
125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20575238 |
126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18798004 |
127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18794864 |
128 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.18766145 |
129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18002162 |
130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16675888 |
131 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.16412256 |
132 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16102641 |
133 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15549897 |
134 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15519423 |
135 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14564862 |
136 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14302174 |
137 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13881011 |
138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13340718 |
139 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12813687 |
140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12714572 |
141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12252157 |
142 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12241493 |
143 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.12166783 |
144 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10690387 |
145 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10636607 |
146 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07476493 |
147 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07392147 |
148 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06898832 |
149 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06818429 |
150 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.06660939 |
151 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05560107 |
152 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05317646 |
153 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.04895521 |
154 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04406239 |
155 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04033795 |
156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03490337 |
157 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03098274 |
158 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01192342 |
159 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01044823 |
160 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00728572 |
161 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98799590 |
162 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97772083 |
163 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97625094 |
164 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96868579 |
165 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96019845 |
166 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95511929 |
167 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95477106 |
168 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95369335 |
169 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.94008582 |
170 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93740059 |
171 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.93146704 |
172 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92527095 |
173 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.92223559 |
174 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92205167 |
175 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91889559 |
176 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91670417 |
177 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91344090 |
178 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91139380 |
179 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89255242 |
180 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88793230 |
181 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88219429 |
182 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85695557 |
183 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83148830 |
184 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82429979 |
185 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81764098 |
186 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80303967 |
187 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80293182 |
188 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78031840 |
189 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77999388 |
190 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77517425 |
191 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77260251 |
192 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75808610 |
193 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75150153 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.85690710 |
2 | MP0003724_increased_susceptibility_to | 3.73566241 |
3 | MP0001835_abnormal_antigen_presentation | 3.70868417 |
4 | MP0003436_decreased_susceptibility_to | 3.34627861 |
5 | MP0003880_abnormal_central_pattern | 3.33516480 |
6 | MP0005671_abnormal_response_to | 3.09111773 |
7 | MP0009785_altered_susceptibility_to | 3.07249494 |
8 | MP0001790_abnormal_immune_system | 3.04744310 |
9 | MP0005387_immune_system_phenotype | 3.04744310 |
10 | MP0005000_abnormal_immune_tolerance | 2.99028012 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.97141374 |
12 | MP0006082_CNS_inflammation | 2.82387275 |
13 | MP0000685_abnormal_immune_system | 2.72840567 |
14 | MP0003122_maternal_imprinting | 2.68352976 |
15 | MP0002419_abnormal_innate_immunity | 2.66613336 |
16 | MP0001800_abnormal_humoral_immune | 2.66393498 |
17 | MP0003300_gastrointestinal_ulcer | 2.59637569 |
18 | * MP0005025_abnormal_response_to | 2.57635126 |
19 | MP0002452_abnormal_antigen_presenting | 2.49639761 |
20 | MP0002723_abnormal_immune_serum | 2.40834029 |
21 | MP0004510_myositis | 2.40098371 |
22 | MP0005058_abnormal_lysosome_morphology | 2.39739939 |
23 | MP0001529_abnormal_vocalization | 2.39307364 |
24 | MP0008057_abnormal_DNA_replication | 2.22530282 |
25 | MP0005423_abnormal_somatic_nervous | 2.15863793 |
26 | MP0002420_abnormal_adaptive_immunity | 2.14609237 |
27 | MP0004859_abnormal_synaptic_plasticity | 2.13865179 |
28 | MP0004957_abnormal_blastocyst_morpholog | 2.13683434 |
29 | MP0001819_abnormal_immune_cell | 2.13050226 |
30 | MP0003693_abnormal_embryo_hatching | 2.10499706 |
31 | MP0005464_abnormal_platelet_physiology | 1.97734859 |
32 | MP0008932_abnormal_embryonic_tissue | 1.97609274 |
33 | MP0001533_abnormal_skeleton_physiology | 1.97575480 |
34 | MP0003123_paternal_imprinting | 1.96095525 |
35 | MP0004947_skin_inflammation | 1.94746445 |
36 | MP0005451_abnormal_body_composition | 1.93980668 |
37 | MP0003077_abnormal_cell_cycle | 1.93376068 |
38 | MP0010094_abnormal_chromosome_stability | 1.92799849 |
39 | MP0009278_abnormal_bone_marrow | 1.92006050 |
40 | MP0003111_abnormal_nucleus_morphology | 1.87401529 |
41 | MP0004133_heterotaxia | 1.84358533 |
42 | MP0002653_abnormal_ependyma_morphology | 1.82603859 |
43 | MP0006276_abnormal_autonomic_nervous | 1.82554526 |
44 | MP0001845_abnormal_inflammatory_respons | 1.80402549 |
45 | MP0001853_heart_inflammation | 1.80374747 |
46 | MP0010030_abnormal_orbit_morphology | 1.80157657 |
47 | MP0003075_altered_response_to | 1.78891060 |
48 | MP0010155_abnormal_intestine_physiology | 1.77106003 |
49 | MP0000343_altered_response_to | 1.74476752 |
50 | MP0002405_respiratory_system_inflammati | 1.73901710 |
51 | MP0003191_abnormal_cellular_cholesterol | 1.69681747 |
52 | MP0003121_genomic_imprinting | 1.67067959 |
53 | MP0008004_abnormal_stomach_pH | 1.66530678 |
54 | MP0009840_abnormal_foam_cell | 1.66395986 |
55 | MP0009764_decreased_sensitivity_to | 1.65217421 |
56 | MP0000716_abnormal_immune_system | 1.60352097 |
57 | MP0003635_abnormal_synaptic_transmissio | 1.59130242 |
58 | MP0004858_abnormal_nervous_system | 1.56431189 |
59 | MP0002998_abnormal_bone_remodeling | 1.55802086 |
60 | MP0001968_abnormal_touch/_nociception | 1.54784315 |
61 | MP0001545_abnormal_hematopoietic_system | 1.54371706 |
62 | MP0005397_hematopoietic_system_phenotyp | 1.54371706 |
63 | MP0002398_abnormal_bone_marrow | 1.53786023 |
64 | MP0008469_abnormal_protein_level | 1.52364023 |
65 | MP0004270_analgesia | 1.50861847 |
66 | MP0003763_abnormal_thymus_physiology | 1.47149460 |
67 | MP0005310_abnormal_salivary_gland | 1.46926045 |
68 | MP0008058_abnormal_DNA_repair | 1.46241093 |
69 | MP0000604_amyloidosis | 1.45549473 |
70 | MP0001905_abnormal_dopamine_level | 1.41397074 |
71 | MP0003448_altered_tumor_morphology | 1.33029951 |
72 | MP0000858_altered_metastatic_potential | 1.32843136 |
73 | MP0002735_abnormal_chemical_nociception | 1.32241708 |
74 | MP0000689_abnormal_spleen_morphology | 1.32002197 |
75 | MP0002064_seizures | 1.31878528 |
76 | MP0001730_embryonic_growth_arrest | 1.30513621 |
77 | MP0003690_abnormal_glial_cell | 1.30400654 |
78 | MP0002736_abnormal_nociception_after | 1.29927676 |
79 | MP0002751_abnormal_autonomic_nervous | 1.28873192 |
80 | MP0000350_abnormal_cell_proliferation | 1.28298378 |
81 | MP0005166_decreased_susceptibility_to | 1.27989092 |
82 | MP0002138_abnormal_hepatobiliary_system | 1.27511685 |
83 | MP0003828_pulmonary_edema | 1.27146560 |
84 | MP0002429_abnormal_blood_cell | 1.27097467 |
85 | MP0002063_abnormal_learning/memory/cond | 1.26463196 |
86 | MP0006072_abnormal_retinal_apoptosis | 1.26278674 |
87 | MP0002734_abnormal_mechanical_nocicepti | 1.26103682 |
88 | MP0001970_abnormal_pain_threshold | 1.22679534 |
89 | MP0002733_abnormal_thermal_nociception | 1.21952164 |
90 | MP0000778_abnormal_nervous_system | 1.21827821 |
91 | MP0000955_abnormal_spinal_cord | 1.20931468 |
92 | MP0002722_abnormal_immune_system | 1.20791917 |
93 | MP0004142_abnormal_muscle_tone | 1.20752771 |
94 | MP0003183_abnormal_peptide_metabolism | 1.19836932 |
95 | MP0002272_abnormal_nervous_system | 1.18094781 |
96 | MP0001348_abnormal_lacrimal_gland | 1.16995726 |
97 | MP0003091_abnormal_cell_migration | 1.16890576 |
98 | MP0002184_abnormal_innervation | 1.16673139 |
99 | MP0002139_abnormal_hepatobiliary_system | 1.13663601 |
100 | MP0005167_abnormal_blood-brain_barrier | 1.13297819 |
101 | MP0009046_muscle_twitch | 1.13158580 |
102 | MP0002332_abnormal_exercise_endurance | 1.12184235 |
103 | MP0004811_abnormal_neuron_physiology | 1.12042369 |
104 | MP0003453_abnormal_keratinocyte_physiol | 1.11997732 |
105 | MP0002572_abnormal_emotion/affect_behav | 1.11873701 |
106 | MP0006292_abnormal_olfactory_placode | 1.11287722 |
107 | MP0002254_reproductive_system_inflammat | 1.08963105 |
108 | MP0004233_abnormal_muscle_weight | 1.08781840 |
109 | MP0001986_abnormal_taste_sensitivity | 1.06338021 |
110 | MP0008007_abnormal_cellular_replicative | 1.05268694 |
111 | MP0003283_abnormal_digestive_organ | 1.03670312 |
112 | MP0005623_abnormal_meninges_morphology | 1.01997306 |
113 | MP0001697_abnormal_embryo_size | 1.01934639 |
114 | MP0000465_gastrointestinal_hemorrhage | 1.01778954 |
115 | MP0000751_myopathy | 1.01069950 |
116 | MP0002638_abnormal_pupillary_reflex | 1.00581578 |
117 | MP0003119_abnormal_digestive_system | 0.99953540 |
118 | MP0009763_increased_sensitivity_to | 0.99512410 |
119 | MP0004883_abnormal_blood_vessel | 0.98939149 |
120 | MP0009745_abnormal_behavioral_response | 0.98477856 |
121 | MP0003861_abnormal_nervous_system | 0.98173630 |
122 | MP0005164_abnormal_response_to | 0.97236220 |
123 | MP0002166_altered_tumor_susceptibility | 0.95868897 |
124 | MP0002102_abnormal_ear_morphology | 0.95858167 |
125 | MP0004808_abnormal_hematopoietic_stem | 0.95125929 |
126 | MP0002085_abnormal_embryonic_tissue | 0.93899317 |
127 | MP0002882_abnormal_neuron_morphology | 0.93618568 |
128 | MP0001851_eye_inflammation | 0.93081146 |
129 | MP0005394_taste/olfaction_phenotype | 0.92906237 |
130 | MP0005499_abnormal_olfactory_system | 0.92906237 |
131 | MP0008877_abnormal_DNA_methylation | 0.92483971 |
132 | MP0003656_abnormal_erythrocyte_physiolo | 0.92131849 |
133 | MP0002152_abnormal_brain_morphology | 0.89446159 |
134 | MP0005165_increased_susceptibility_to | 0.89110607 |
135 | MP0000049_abnormal_middle_ear | 0.88827640 |
136 | MP0000358_abnormal_cell_content/ | 0.87756762 |
137 | MP0008569_lethality_at_weaning | 0.87545892 |
138 | MP0002933_joint_inflammation | 0.86529349 |
139 | MP0005390_skeleton_phenotype | 0.86512095 |
140 | MP0003045_fibrosis | 0.86279184 |
141 | MP0002080_prenatal_lethality | 0.85535476 |
142 | MP0000313_abnormal_cell_death | 0.84433297 |
143 | MP0000249_abnormal_blood_vessel | 0.83682696 |
144 | MP0002084_abnormal_developmental_patter | 0.83357626 |
145 | MP0008789_abnormal_olfactory_epithelium | 0.83152293 |
146 | MP0003315_abnormal_perineum_morphology | 0.82946746 |
147 | MP0003806_abnormal_nucleotide_metabolis | 0.82103931 |
148 | MP0001542_abnormal_bone_strength | 0.81851985 |
149 | MP0003634_abnormal_glial_cell | 0.79453632 |
150 | MP0002067_abnormal_sensory_capabilities | 0.79236760 |
151 | MP0002006_tumorigenesis | 0.78207677 |
152 | MP0004145_abnormal_muscle_electrophysio | 0.77291498 |
153 | MP0008874_decreased_physiological_sensi | 0.76668039 |
154 | MP0001663_abnormal_digestive_system | 0.76372869 |
155 | MP0000703_abnormal_thymus_morphology | 0.75386197 |
156 | MP0001984_abnormal_olfaction | 0.75197434 |
157 | MP0001873_stomach_inflammation | 0.75157431 |
158 | MP0001440_abnormal_grooming_behavior | 0.74781349 |
159 | MP0003795_abnormal_bone_structure | 0.73861519 |
160 | MP0002752_abnormal_somatic_nervous | 0.73652575 |
161 | MP0003942_abnormal_urinary_system | 0.73194149 |
162 | MP0006054_spinal_hemorrhage | 0.72684149 |
163 | MP0003786_premature_aging | 0.72034360 |
164 | MP0002877_abnormal_melanocyte_morpholog | 0.71909351 |
165 | MP0009333_abnormal_splenocyte_physiolog | 0.70256596 |
166 | MP0002066_abnormal_motor_capabilities/c | 0.69989244 |
167 | MP0005253_abnormal_eye_physiology | 0.69287814 |
168 | MP0003938_abnormal_ear_development | 0.68842781 |
169 | MP0000537_abnormal_urethra_morphology | 0.68354101 |
170 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68050059 |
171 | MP0001486_abnormal_startle_reflex | 0.67503775 |
172 | MP0005666_abnormal_adipose_tissue | 0.67203705 |
173 | MP0006035_abnormal_mitochondrial_morpho | 0.67100489 |
174 | MP0009765_abnormal_xenobiotic_induced | 0.66033701 |
175 | MP0002089_abnormal_postnatal_growth/wei | 0.65523934 |
176 | MP0000920_abnormal_myelination | 0.64839575 |
177 | MP0005384_cellular_phenotype | 0.64239171 |
178 | MP0003866_abnormal_defecation | 0.64212668 |
179 | MP0000534_abnormal_ureter_morphology | 0.63311782 |
180 | MP0002557_abnormal_social/conspecific_i | 0.62985976 |
181 | MP0001672_abnormal_embryogenesis/_devel | 0.62620556 |
182 | MP0005380_embryogenesis_phenotype | 0.62620556 |
183 | MP0003329_amyloid_beta_deposits | 0.62414906 |
184 | MP0003172_abnormal_lysosome_physiology | 0.61965680 |
185 | MP0003137_abnormal_impulse_conducting | 0.61539768 |
186 | MP0000631_abnormal_neuroendocrine_gland | 0.61423775 |
187 | MP0005386_behavior/neurological_phenoty | 0.61381567 |
188 | MP0004924_abnormal_behavior | 0.61381567 |
189 | MP0005023_abnormal_wound_healing | 0.59640279 |
190 | MP0005647_abnormal_sex_gland | 0.59309438 |
191 | MP0003279_aneurysm | 0.58294875 |
192 | MP0000749_muscle_degeneration | 0.57546530 |
193 | MP0008260_abnormal_autophagy | 0.57115909 |
194 | MP0000609_abnormal_liver_physiology | 0.52455595 |
195 | MP0005535_abnormal_body_temperature | 0.52026072 |
196 | MP0003646_muscle_fatigue | 0.50610249 |
197 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.48854190 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of macrophages (HP:0004311) | 5.05042543 |
2 | Eczematoid dermatitis (HP:0000976) | 4.92380015 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.87233966 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.87233966 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.87233966 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.86461645 |
7 | Recurrent abscess formation (HP:0002722) | 4.64132127 |
8 | Orchitis (HP:0100796) | 4.24547574 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.12980480 |
10 | Optic neuritis (HP:0100653) | 4.12980480 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 4.12618915 |
12 | Myositis (HP:0100614) | 4.07316445 |
13 | Systemic lupus erythematosus (HP:0002725) | 3.67320435 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61931449 |
15 | Cerebral hypomyelination (HP:0006808) | 3.56269202 |
16 | Vasculitis (HP:0002633) | 3.50061003 |
17 | Gastrointestinal stroma tumor (HP:0100723) | 3.45975904 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.42403070 |
19 | Meningitis (HP:0001287) | 3.39808251 |
20 | Increased cerebral lipofuscin (HP:0011813) | 3.31912385 |
21 | Dysostosis multiplex (HP:0000943) | 3.30680506 |
22 | Recurrent viral infections (HP:0004429) | 3.28787755 |
23 | Loss of speech (HP:0002371) | 3.28683223 |
24 | Stomatitis (HP:0010280) | 3.24986500 |
25 | Myokymia (HP:0002411) | 3.21398993 |
26 | Recurrent fungal infections (HP:0002841) | 3.13665884 |
27 | Pulmonary infiltrates (HP:0002113) | 3.10024741 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10010600 |
29 | Recurrent skin infections (HP:0001581) | 3.09211915 |
30 | Cellulitis (HP:0100658) | 3.01061487 |
31 | Autoimmune thrombocytopenia (HP:0001973) | 3.00450392 |
32 | Keratoconjunctivitis sicca (HP:0001097) | 2.97630734 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95885776 |
34 | Obstructive lung disease (HP:0006536) | 2.95885776 |
35 | Spontaneous hematomas (HP:0007420) | 2.91884913 |
36 | Increased IgM level (HP:0003496) | 2.87514804 |
37 | Colitis (HP:0002583) | 2.80534276 |
38 | Purpura (HP:0000979) | 2.79347976 |
39 | Disinhibition (HP:0000734) | 2.73924856 |
40 | Degeneration of anterior horn cells (HP:0002398) | 2.68729020 |
41 | Abnormality of the anterior horn cell (HP:0006802) | 2.68729020 |
42 | Urticaria (HP:0001025) | 2.66865637 |
43 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.66339359 |
44 | Keratoconjunctivitis (HP:0001096) | 2.66243187 |
45 | Agammaglobulinemia (HP:0004432) | 2.65937637 |
46 | Increased IgE level (HP:0003212) | 2.64440851 |
47 | Encephalitis (HP:0002383) | 2.62979360 |
48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62249445 |
49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62249445 |
50 | Hemoptysis (HP:0002105) | 2.61710715 |
51 | Petechiae (HP:0000967) | 2.59853432 |
52 | Abnormality of the labia minora (HP:0012880) | 2.58970022 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.56917871 |
54 | Gingivitis (HP:0000230) | 2.53745680 |
55 | Interstitial pulmonary disease (HP:0006530) | 2.52856043 |
56 | Arterial thrombosis (HP:0004420) | 2.50722595 |
57 | Acute necrotizing encephalopathy (HP:0006965) | 2.49221815 |
58 | Gastrointestinal infarctions (HP:0005244) | 2.48836696 |
59 | Birth length less than 3rd percentile (HP:0003561) | 2.47197232 |
60 | IgA deficiency (HP:0002720) | 2.47034687 |
61 | T lymphocytopenia (HP:0005403) | 2.46692566 |
62 | Abnormal number of incisors (HP:0011064) | 2.44260669 |
63 | Inflammation of the large intestine (HP:0002037) | 2.43830948 |
64 | Restrictive lung disease (HP:0002091) | 2.43661355 |
65 | Abnormality of glycolysis (HP:0004366) | 2.43029041 |
66 | Increased serum pyruvate (HP:0003542) | 2.43029041 |
67 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.41620986 |
68 | Abnormality of T cell number (HP:0011839) | 2.39372355 |
69 | Recurrent bronchitis (HP:0002837) | 2.39298591 |
70 | Lymphopenia (HP:0001888) | 2.38370230 |
71 | Osteomyelitis (HP:0002754) | 2.37734783 |
72 | Autoimmune hemolytic anemia (HP:0001890) | 2.37588936 |
73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37074264 |
74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37074264 |
75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37074264 |
76 | Hypergammaglobulinemia (HP:0010702) | 2.36799529 |
77 | Myocardial infarction (HP:0001658) | 2.36316238 |
78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.35812324 |
79 | Amyloidosis (HP:0011034) | 2.34811663 |
80 | Chest pain (HP:0100749) | 2.34710160 |
81 | Hepatosplenomegaly (HP:0001433) | 2.34600264 |
82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32574498 |
83 | Mucopolysacchariduria (HP:0008155) | 2.32574498 |
84 | Gastrointestinal inflammation (HP:0004386) | 2.30540776 |
85 | Emphysema (HP:0002097) | 2.28887121 |
86 | Gangrene (HP:0100758) | 2.26508037 |
87 | Increased serum ferritin (HP:0003281) | 2.26023152 |
88 | Supernumerary spleens (HP:0009799) | 2.25732388 |
89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25457607 |
90 | Patellar aplasia (HP:0006443) | 2.24775054 |
91 | Epistaxis (HP:0000421) | 2.22775391 |
92 | Hematochezia (HP:0002573) | 2.21331349 |
93 | Premature loss of primary teeth (HP:0006323) | 2.19171119 |
94 | Mitochondrial inheritance (HP:0001427) | 2.18717172 |
95 | Prolonged bleeding time (HP:0003010) | 2.17150961 |
96 | Glomerulonephritis (HP:0000099) | 2.17060678 |
97 | Failure to thrive in infancy (HP:0001531) | 2.16581994 |
98 | Recurrent sinusitis (HP:0011108) | 2.14830219 |
99 | Arthralgia (HP:0002829) | 2.14362217 |
100 | Gingival bleeding (HP:0000225) | 2.13492990 |
101 | Asymmetric septal hypertrophy (HP:0001670) | 2.13472745 |
102 | Basal ganglia calcification (HP:0002135) | 2.13337156 |
103 | Recurrent pneumonia (HP:0006532) | 2.12755658 |
104 | Mutism (HP:0002300) | 2.12420567 |
105 | Polyneuropathy (HP:0001271) | 2.12102328 |
106 | Neuroendocrine neoplasm (HP:0100634) | 2.12007059 |
107 | Abnormality of the pleura (HP:0002103) | 2.11325223 |
108 | Ependymoma (HP:0002888) | 2.09058142 |
109 | Emotional lability (HP:0000712) | 2.08959936 |
110 | Selective tooth agenesis (HP:0001592) | 2.06744310 |
111 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.05698031 |
112 | Rectal fistula (HP:0100590) | 2.04742926 |
113 | Rectovaginal fistula (HP:0000143) | 2.04742926 |
114 | Pulmonary embolism (HP:0002204) | 2.04022023 |
115 | Breast hypoplasia (HP:0003187) | 2.03990626 |
116 | Pheochromocytoma (HP:0002666) | 2.03788802 |
117 | Abnormality of T cells (HP:0002843) | 2.03461954 |
118 | Amaurosis fugax (HP:0100576) | 2.03196941 |
119 | Joint swelling (HP:0001386) | 2.01359369 |
120 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01071627 |
121 | IgM deficiency (HP:0002850) | 2.00126745 |
122 | Leukocytosis (HP:0001974) | 2.00035742 |
123 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98947512 |
124 | Hypertensive crisis (HP:0100735) | 1.96278555 |
125 | Postnatal microcephaly (HP:0005484) | 1.95257343 |
126 | Vertigo (HP:0002321) | 1.95034302 |
127 | Delusions (HP:0000746) | 1.94705136 |
128 | Visual hallucinations (HP:0002367) | 1.93504719 |
129 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.91645173 |
130 | Limb dystonia (HP:0002451) | 1.91210904 |
131 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90743033 |
132 | Aplasia involving forearm bones (HP:0009822) | 1.90688672 |
133 | Absent forearm bone (HP:0003953) | 1.90688672 |
134 | CNS hypomyelination (HP:0003429) | 1.89789552 |
135 | Absent radius (HP:0003974) | 1.89340919 |
136 | Broad alveolar ridges (HP:0000187) | 1.88304670 |
137 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.86859503 |
138 | Agnosia (HP:0010524) | 1.83548368 |
139 | Hepatocellular necrosis (HP:0001404) | 1.83443679 |
140 | Increased CSF lactate (HP:0002490) | 1.80600657 |
141 | High anterior hairline (HP:0009890) | 1.80581187 |
142 | Shoulder girdle muscle weakness (HP:0003547) | 1.76774280 |
143 | Atonic seizures (HP:0010819) | 1.76181229 |
144 | Reticulocytopenia (HP:0001896) | 1.76113240 |
145 | Lissencephaly (HP:0001339) | 1.76106381 |
146 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.75814834 |
147 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.75814834 |
148 | Trismus (HP:0000211) | 1.73783028 |
149 | Amyotrophic lateral sclerosis (HP:0007354) | 1.72947588 |
150 | Tongue fasciculations (HP:0001308) | 1.72552785 |
151 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.72440062 |
152 | Orthostatic hypotension (HP:0001278) | 1.72116055 |
153 | Asplenia (HP:0001746) | 1.71107600 |
154 | Aplastic anemia (HP:0001915) | 1.70765812 |
155 | Stenosis of the external auditory canal (HP:0000402) | 1.68893805 |
156 | Progressive macrocephaly (HP:0004481) | 1.68338284 |
157 | Ankle clonus (HP:0011448) | 1.68330878 |
158 | Severe visual impairment (HP:0001141) | 1.68322379 |
159 | Leukodystrophy (HP:0002415) | 1.66941183 |
160 | Focal motor seizures (HP:0011153) | 1.66800140 |
161 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.66639526 |
162 | Carpal bone hypoplasia (HP:0001498) | 1.66229115 |
163 | Abnormal hair whorl (HP:0010721) | 1.64924979 |
164 | Broad distal phalanx of finger (HP:0009836) | 1.61975540 |
165 | Vaginal fistula (HP:0004320) | 1.61857174 |
166 | 3-Methylglutaconic aciduria (HP:0003535) | 1.60872418 |
167 | Colon cancer (HP:0003003) | 1.60112222 |
168 | Exercise intolerance (HP:0003546) | 1.59314168 |
169 | Abnormality of binocular vision (HP:0011514) | 1.58095414 |
170 | Diplopia (HP:0000651) | 1.58095414 |
171 | Unsteady gait (HP:0002317) | 1.58049612 |
172 | Abnormal number of erythroid precursors (HP:0012131) | 1.57909701 |
173 | Fused cervical vertebrae (HP:0002949) | 1.56819081 |
174 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.56190279 |
175 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.55935894 |
176 | Increased hepatocellular lipid droplets (HP:0006565) | 1.55073571 |
177 | Septo-optic dysplasia (HP:0100842) | 1.53123920 |
178 | Polyphagia (HP:0002591) | 1.52843117 |
179 | Partial duplication of the phalanx of hand (HP:0009999) | 1.52082662 |
180 | Partial duplication of thumb phalanx (HP:0009944) | 1.52033007 |
181 | Intestinal fistula (HP:0100819) | 1.51506774 |
182 | Muscle fibrillation (HP:0010546) | 1.51134397 |
183 | Personality changes (HP:0000751) | 1.51091105 |
184 | Medulloblastoma (HP:0002885) | 1.50872788 |
185 | Poor suck (HP:0002033) | 1.49439679 |
186 | Supranuclear gaze palsy (HP:0000605) | 1.48916562 |
187 | Increased serum lactate (HP:0002151) | 1.48811825 |
188 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.48640568 |
189 | Split foot (HP:0001839) | 1.47892659 |
190 | Dysautonomia (HP:0002459) | 1.47199872 |
191 | Abnormality of the ileum (HP:0001549) | 1.47004353 |
192 | Gait imbalance (HP:0002141) | 1.46382083 |
193 | Epileptic encephalopathy (HP:0200134) | 1.46195373 |
194 | Abnormal sex determination (HP:0012244) | 1.43243563 |
195 | Sex reversal (HP:0012245) | 1.43243563 |
196 | Diminished motivation (HP:0000745) | 1.42878932 |
197 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.42236909 |
198 | Abnormality of abdominal situs (HP:0011620) | 1.42042554 |
199 | Abdominal situs inversus (HP:0003363) | 1.42042554 |
200 | Hemiparesis (HP:0001269) | 1.41440615 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 5.59807688 |
2 | MAP3K14 | 3.18684113 |
3 | TYK2 | 2.91871420 |
4 | MAP3K9 | 2.73694518 |
5 | ERN1 | 2.71853131 |
6 | TESK2 | 2.68685322 |
7 | IRAK3 | 2.67321467 |
8 | ARAF | 2.61661679 |
9 | TBK1 | 2.56093473 |
10 | IRAK4 | 2.50561127 |
11 | WEE1 | 2.40784363 |
12 | TSSK6 | 2.26769203 |
13 | IKBKE | 2.19490439 |
14 | UHMK1 | 2.14588439 |
15 | CSK | 2.13460905 |
16 | NEK1 | 2.06115370 |
17 | MAP3K13 | 2.03356739 |
18 | GRK7 | 1.97999232 |
19 | JAK3 | 1.95467093 |
20 | CDK19 | 1.92013854 |
21 | JAK1 | 1.80986719 |
22 | STK16 | 1.80719902 |
23 | IKBKB | 1.79566199 |
24 | DYRK2 | 1.77200871 |
25 | LIMK1 | 1.74392238 |
26 | BMPR2 | 1.73459885 |
27 | MINK1 | 1.70691670 |
28 | SYK | 1.66529734 |
29 | NME2 | 1.65042329 |
30 | TGFBR2 | 1.62242345 |
31 | MAP3K12 | 1.60131445 |
32 | PNCK | 1.59588546 |
33 | BTK | 1.59202829 |
34 | MAP2K3 | 1.57227519 |
35 | CCNB1 | 1.56916548 |
36 | DDR2 | 1.56213303 |
37 | CSF1R | 1.54153417 |
38 | SIK3 | 1.53318072 |
39 | EIF2AK1 | 1.52644294 |
40 | MARK1 | 1.48446194 |
41 | CDK14 | 1.47472135 |
42 | CDK18 | 1.44045108 |
43 | ZAP70 | 1.41681288 |
44 | MAP3K3 | 1.40876739 |
45 | TLK1 | 1.40396577 |
46 | FES | 1.40376221 |
47 | BCR | 1.38526609 |
48 | BRAF | 1.37003707 |
49 | CDK15 | 1.35339582 |
50 | NEK9 | 1.33018435 |
51 | VRK1 | 1.30585520 |
52 | LYN | 1.30212287 |
53 | MAPK13 | 1.29559472 |
54 | KSR1 | 1.29526506 |
55 | CDK11A | 1.27656523 |
56 | DAPK1 | 1.26659838 |
57 | KIT | 1.25964491 |
58 | BRSK1 | 1.25813922 |
59 | CDC42BPA | 1.24210508 |
60 | JAK2 | 1.23631943 |
61 | MAPKAPK3 | 1.23378690 |
62 | TXK | 1.21593118 |
63 | TESK1 | 1.20786439 |
64 | RIPK1 | 1.20196313 |
65 | AURKA | 1.17909585 |
66 | HCK | 1.17620670 |
67 | PLK1 | 1.15974472 |
68 | TAOK1 | 1.15872327 |
69 | DYRK3 | 1.15296760 |
70 | CDC7 | 1.15216260 |
71 | MAP3K1 | 1.14654494 |
72 | PIM2 | 1.13950546 |
73 | NTRK2 | 1.12946452 |
74 | PAK1 | 1.10880586 |
75 | TNK2 | 1.06547960 |
76 | ACVR1B | 1.04522522 |
77 | PAK4 | 1.03346132 |
78 | FGFR4 | 1.02172515 |
79 | PASK | 1.01314199 |
80 | GRK5 | 1.00876759 |
81 | STK24 | 0.99080819 |
82 | TEC | 0.98446198 |
83 | IRAK1 | 0.98240567 |
84 | EPHB1 | 0.96438480 |
85 | PLK3 | 0.95211272 |
86 | RPS6KB2 | 0.94274998 |
87 | KSR2 | 0.94224867 |
88 | NEK2 | 0.93654398 |
89 | LCK | 0.92656240 |
90 | MATK | 0.91591918 |
91 | CHUK | 0.91528155 |
92 | TYRO3 | 0.89643811 |
93 | NME1 | 0.88577591 |
94 | PLK2 | 0.88032838 |
95 | ITK | 0.85352058 |
96 | ILK | 0.83484161 |
97 | PAK6 | 0.81948855 |
98 | NTRK1 | 0.81272345 |
99 | MARK3 | 0.79638735 |
100 | MAPK7 | 0.78738150 |
101 | TRIB3 | 0.78323862 |
102 | MOS | 0.78159780 |
103 | TGFBR1 | 0.73509276 |
104 | IRAK2 | 0.73066968 |
105 | TTK | 0.72560983 |
106 | PRKD3 | 0.71807467 |
107 | EPHA3 | 0.71159434 |
108 | LATS2 | 0.71133577 |
109 | TTN | 0.70755640 |
110 | MAPK12 | 0.70108550 |
111 | MAP3K5 | 0.69860156 |
112 | EEF2K | 0.68151323 |
113 | ROCK2 | 0.66664625 |
114 | PDK1 | 0.65550938 |
115 | MAPKAPK5 | 0.64285188 |
116 | PRPF4B | 0.63396630 |
117 | RAF1 | 0.62483507 |
118 | PDPK1 | 0.60072302 |
119 | FGFR3 | 0.59700323 |
120 | PRKCQ | 0.59597672 |
121 | SCYL2 | 0.59067566 |
122 | CHEK2 | 0.58831096 |
123 | MAP3K10 | 0.58304619 |
124 | CDK8 | 0.58287381 |
125 | MST4 | 0.55334290 |
126 | MAP3K11 | 0.54650363 |
127 | CDK5 | 0.54151709 |
128 | DAPK3 | 0.54087310 |
129 | GRK6 | 0.53621642 |
130 | CDK7 | 0.53359152 |
131 | SMG1 | 0.51620917 |
132 | MAPK4 | 0.50926513 |
133 | BRSK2 | 0.50725431 |
134 | NTRK3 | 0.50661169 |
135 | HIPK2 | 0.50657131 |
136 | TAOK3 | 0.50541797 |
137 | ADRBK1 | 0.50479927 |
138 | PHKG2 | 0.49763530 |
139 | PHKG1 | 0.49763530 |
140 | PIM1 | 0.49505060 |
141 | PRKCI | 0.49338640 |
142 | ADRBK2 | 0.49147291 |
143 | MAP3K8 | 0.48887672 |
144 | FGR | 0.47744169 |
145 | STK10 | 0.47117448 |
146 | BLK | 0.47114046 |
147 | ALK | 0.46940614 |
148 | CSNK1G3 | 0.46739325 |
149 | MAP3K4 | 0.45861786 |
150 | ATR | 0.45011530 |
151 | ICK | 0.44155345 |
152 | RPS6KA4 | 0.43839303 |
153 | CLK1 | 0.42954938 |
154 | CDK6 | 0.42065504 |
155 | SIK1 | 0.41335538 |
156 | MAPK11 | 0.41037787 |
157 | MAPKAPK2 | 0.40725755 |
158 | MAP4K1 | 0.40369505 |
159 | BMX | 0.39958642 |
160 | CDK4 | 0.39552025 |
161 | PIK3CG | 0.38902715 |
162 | CHEK1 | 0.38633742 |
163 | RIPK4 | 0.38550317 |
164 | TAOK2 | 0.37693969 |
165 | TRPM7 | 0.37234536 |
166 | CDK2 | 0.35702055 |
167 | LRRK2 | 0.35340107 |
168 | FYN | 0.34484738 |
169 | SIK2 | 0.34280183 |
170 | ABL1 | 0.32824021 |
171 | MARK2 | 0.31883491 |
172 | PRKCD | 0.30522681 |
173 | RPS6KL1 | 0.29579180 |
174 | RPS6KC1 | 0.29579180 |
175 | KDR | 0.29487678 |
176 | INSR | 0.27818698 |
177 | YES1 | 0.27367950 |
178 | PKN1 | 0.27354411 |
179 | ABL2 | 0.25924992 |
180 | EGFR | 0.23049155 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.45132624 |
2 | Proteasome_Homo sapiens_hsa03050 | 3.32099312 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.09051583 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.02056164 |
5 | Asthma_Homo sapiens_hsa05310 | 2.94966411 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.92240897 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.88839481 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.80102314 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.78899139 |
10 | DNA replication_Homo sapiens_hsa03030 | 2.78894448 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56383185 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.53939601 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.43323898 |
14 | Spliceosome_Homo sapiens_hsa03040 | 2.42890385 |
15 | Mismatch repair_Homo sapiens_hsa03430 | 2.41954189 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35434545 |
17 | Parkinsons disease_Homo sapiens_hsa05012 | 2.22158152 |
18 | Base excision repair_Homo sapiens_hsa03410 | 2.20677659 |
19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.19317994 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11942552 |
21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06916716 |
22 | RNA polymerase_Homo sapiens_hsa03020 | 2.06291912 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 2.02148339 |
24 | RNA transport_Homo sapiens_hsa03013 | 1.82945525 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.82754219 |
26 | Malaria_Homo sapiens_hsa05144 | 1.82471913 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71458322 |
28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71207516 |
29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.70454728 |
30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.70243360 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70161380 |
32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69390914 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69239535 |
34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.68958455 |
35 | Cell cycle_Homo sapiens_hsa04110 | 1.66669032 |
36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.63616482 |
37 | Pertussis_Homo sapiens_hsa05133 | 1.62400262 |
38 | Measles_Homo sapiens_hsa05162 | 1.61411511 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.60446135 |
40 | Legionellosis_Homo sapiens_hsa05134 | 1.56627038 |
41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.55898462 |
42 | Homologous recombination_Homo sapiens_hsa03440 | 1.45871188 |
43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.43483584 |
44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40501116 |
45 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.36947502 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.35099297 |
47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34676497 |
48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29457738 |
49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.29156273 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27360341 |
51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24793391 |
52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23696131 |
53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21540603 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19787561 |
55 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.18618024 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15253465 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 1.12317753 |
58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11711624 |
59 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11257533 |
60 | Hepatitis B_Homo sapiens_hsa05161 | 1.08710090 |
61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08608824 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07916827 |
63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07660388 |
64 | Apoptosis_Homo sapiens_hsa04210 | 1.02591098 |
65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.01208447 |
66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99637058 |
67 | Shigellosis_Homo sapiens_hsa05131 | 0.94231713 |
68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.91113900 |
69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90640879 |
70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89435144 |
71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88654452 |
72 | RNA degradation_Homo sapiens_hsa03018 | 0.87879950 |
73 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87721080 |
74 | Protein export_Homo sapiens_hsa03060 | 0.85859300 |
75 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83670507 |
76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82577285 |
77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82235168 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81359816 |
79 | Gap junction_Homo sapiens_hsa04540 | 0.80983680 |
80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80951490 |
81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80291215 |
82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.79627372 |
83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77961367 |
84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77516547 |
85 | Purine metabolism_Homo sapiens_hsa00230 | 0.77165975 |
86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76625163 |
87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76285904 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74610036 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.73523647 |
90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71840736 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71728589 |
92 | Morphine addiction_Homo sapiens_hsa05032 | 0.70327079 |
93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70326940 |
94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69390953 |
95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69262096 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.69150753 |
97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68261497 |
98 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65478297 |
99 | Amoebiasis_Homo sapiens_hsa05146 | 0.64410886 |
100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64108010 |
101 | Alcoholism_Homo sapiens_hsa05034 | 0.63648842 |
102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63291050 |
103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63274318 |
104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62803052 |
105 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62425648 |
106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62413607 |
107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62248589 |
108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60203808 |
109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58660986 |
110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56521489 |
111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56420883 |
112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55636284 |
113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55326707 |
114 | Phagosome_Homo sapiens_hsa04145 | 0.54503998 |
115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54488673 |
116 | Endocytosis_Homo sapiens_hsa04144 | 0.54410202 |
117 | Long-term depression_Homo sapiens_hsa04730 | 0.53027269 |
118 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53007205 |
119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52716745 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50946523 |
121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50580713 |
122 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49886538 |
123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49619182 |
124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49288824 |
125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48155191 |
126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47839304 |
127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47066611 |
128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47063394 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46824115 |
130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46359461 |
131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45531899 |
132 | Axon guidance_Homo sapiens_hsa04360 | 0.45305305 |
133 | Bladder cancer_Homo sapiens_hsa05219 | 0.45291262 |
134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43912790 |
135 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43298943 |
136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43160224 |
137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43057997 |
138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42355770 |
139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41606083 |
140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41393004 |
141 | Phototransduction_Homo sapiens_hsa04744 | 0.40030966 |
142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39839005 |
143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39642065 |
144 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38662250 |
145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38512527 |
146 | Salmonella infection_Homo sapiens_hsa05132 | 0.37679862 |
147 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37140719 |
148 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36878373 |
149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36595855 |
150 | Melanogenesis_Homo sapiens_hsa04916 | 0.36432813 |
151 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35944359 |
152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35908741 |
153 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35614835 |
154 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35553444 |
155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35036783 |
156 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32293595 |
157 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32142813 |
158 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31948876 |
159 | Insulin resistance_Homo sapiens_hsa04931 | 0.31208132 |
160 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27263346 |
161 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24617604 |
162 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23962086 |
163 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19213690 |
164 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17733508 |
165 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.15718943 |
166 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14811958 |
167 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.13425428 |
168 | Prostate cancer_Homo sapiens_hsa05215 | 0.12130160 |